Ems-chemie Holding AgSIX: EMSN

Definitive half-year results 2025 of the EMS Group

· Issued by Ems-chemie Holding AG

Ad hoc announcement pursuant to Art. 53 LR

Herrliberg, August 29, 2025

MEDIA INFORMATION Definitive Half-Year Results 2025 of the EMS Group

On July 11, 2025, the EMS Group published its provisional half-year figures 2025. The definitive half-year figures 2025 are now available, based on the individual financial statements of the affiliated companies as at June 30, 2025. The definitive half-year results show no significant changes to the provisional report.

The EMS Group achieved consolidated net sales amounting to CHF 1,020 million (1,087). Despite a geopolitically hampered environment, a weak industrial economy and a stronger Swiss Franc, EMS was able to generate pleasing new business and significantly increase profitability due to a consistent growth strategy with high-margin specialties and innovation. Net operating income (EBIT) closed at 1.6% above previous year, the margin increased to 29.1%.

As expected, the global economy cooled down further in the first half-year of 2025. Trade tensions and geopolitical conflicts subdued consumers and restrained their purchasing mood and willingness to invest. In the US, consumers and companies are delaying investments with the expectation of higher inflation rates. In Europe, the industry is undergoing restructuring. In China, in particular the high-tech sector is growing. The generally unstable global situation is further strengthening the Swiss Franc in its role as a "safe haven".

Against the general trend, EMS decided to significantly expand the technical sales and development organizations in the main regions Asia, America and Europe. Meanwhile, the expansion programs are already generating pleasing and highly profitable new business. EMS' intensive local development partnerships, strong sales and global delivery capabilities are important pillars for the realization of cost improvements as well as energy and weight savings with customers.

EMS has already prepared in advance for international trade barriers and structured its own supply chains accordingly. Products sold in the US are either produced locally or, being relevant specialties, exempt from duties.

Thanks to the strong position with specialties and with innovation and cost discipline, EMS was able, in a challenging market environment with weaker foreign currencies,

to achieve a net operating income (EBIT) of CHF 296 million (291) and a net operating income before depreciation (EBITDA) of CHF 324 million (319). In this way, the EBIT was 1.6% above previous year, the EBITDA 1.5%. The EBIT margin closed at a high 29.1% (26.8), the EBITDA margin at 31.7% (29.4).

Net financial income amounted to CHF -7 million (-2) due to currency effects. Net income for the first half of 2025 reached CHF 253 million (252), an increase of 0.2% compared to prior year. Equity attributable to the shareholders of the EMS-CHEMIE HOLDING AG increased to CHF 2,072 million (31.12.2024: CHF 1,835 million). The equity ratio was 83.7% (31.12.2024: 82.4%). Olivier Minger, CFO of the EMS Group since October 1, 2023, will take up a new challenge outside the EMS Group as per the end of February 2026. Alexander Hergert, currently CFO of the Business Unit EMS-EFTEC, will transfer to EMS Executive Management as CFO of the EMS Group on March 1, 2026. Key figures EMS Group Half Year 2025

In million CHF

2025

(Jan-Jun)

2024

(Jan-Jun)

Consolidated Income Statement

Net sales

1,020

1,087

% dev. prev. year

- 6.2%

Currency effect

- 2.5%

EBITDA 1)

324

319

% dev. prev. year

+ 1.5%

In % of net sales

31.7%

29.4%

EBIT 2)

296

291

% dev. prev. year

+ 1.6%

In % of net sales

29.1%

26.8%

Net financial income

(7)

(2)

Income taxes

(37)

(37)

Net income

253

252

% dev. prev. year

+ 0.2%

In % of net sales

24.8%

23.2%

Earnings per share in CHF - basic

10.71

10.66

% dev. prev. year

+ 0.4%

Cash flow 3)

199

201

In % of net sales

19.5%

18.5%

Investments

13

13

30.06.2025

31.12.2024

Equity 4)

2,072

1,835

Equity ratio

83.7%

82.4%

% dev. 31.12.2024

+ 12.9%

Equity per share (in CHF)

88.60

78.45

Number of employees

2,755

2,824

EBITDA

=

=

Earnings before Interest, Taxes, Depreciation and Amortization Net operating income before depreciation

EBIT

=

=

Earnings before Interest, Taxes Net operating income

Cash flow

=

Cash flow from operating activities

1)

2)

3)

4)Excluding non-controlling interests

Development of net sales and result from the business areas EMS Group Half Year 2025

In million CHF

2025

(Jan-Jun)

% dev. prev. year

2024

(Jan-Jun)

High Performance Polymers

Net sales

914

- 6.9%

982

Currency effect

- 2.5%

EBITDA

304

+ 1.1%

301

In % of net sales

33.3%

30.7%

EBIT

280

+ 1.1%

276

In % of net sales

30.6%

28.1%

Specialty Chemicals

Net sales

105

+ 0.8%

104

Currency effect

- 2.4%

EBITDA

19

+ 7.4%

18

In % of net sales

18.2%

17.1%

EBIT

17

+ 11.0%

15

In % of net sales

15.9%

14.4%

EMS Group

Net sales

1,020

- 6.2%

1,087

Currency effect

- 2.5%

EBITDA

324

+ 1.5%

319

In % of net sales

31.7%

29.4%

EBIT

296

+ 1.6%

291

In % of net sales

29.1%

26.8%

As the net sales and income results of the individual business areas do not deviate to any significant degree from the information provided in the provisional half-year report dated July 11, 2025, we refer to the comments given therein.

The detailed half-year report is available at https://http://www.ems-group.com/business-financial-reports.

Schedule
  • Third-Quarter Report 2025 October 2025

  • Media conference / Annual Results 2025 February 2026

  • First-Quarter Report 2026 April 2026

  • Media conference / Half-Year Results 2026 July 2026

* * * * * *